Altasciences vs WuXi AppTec

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/altasciences/wuxiapptec

Category	Altasciences	WuXi AppTec
Listed site	both	cro
Summary	Mid-size early phase CRO/CDMO in Canada and the U.S. offering preclinical safety testing, clinical pharmacology (Phase I–II), bioanalysis, research services, and manufacturing with integrated capabilities.	Global CRDMO platform providing integrated end-to-end contract research, development, and manufacturing services across discovery, preclinical, clinical, and commercial phases for small molecules, peptides, oligonucleotides, and biologics across 30+ countries.
Services	Preclinical In Vivo Studies GLP Toxicology Safety Pharmacology In Vitro Pharmacology Phase I Clinical Trials Phase II Clinical Trials Clinical Trial Services Bioanalysis Ligand-Binding Bioanalysis (Large Molecule) Analytical Method Development & Validation ICH Stability Studies Biostatistics & Statistical Programming Data Management & eClinical Medical Writing Clinical Operations Regulatory Affairs In Vivo PK / PD Studies Preclinical In Vitro Studies Phase IV / Post-Marketing In Vitro ADME / DMPK Formulation Development Stability Testing & Storage	Discovery Research Target Identification & Validation High-Throughput Screening Medicinal Chemistry Computational & In-Silico Drug Discovery Protein Engineering Preclinical In Vitro Studies In Vitro Pharmacology In Vitro ADME / DMPK Safety Pharmacology Genetic Toxicology Preclinical In Vivo Studies In Vivo Efficacy Models In Vivo PK / PD Studies GLP Toxicology Carcinogenicity Studies DART (Reproductive & Developmental Toxicology) Specialized & Large-Animal Models Bioanalysis LC-MS Bioanalysis (Small Molecule) Ligand-Binding Bioanalysis (Large Molecule) Immunogenicity Assays (ADA / NAb) Biomarker Assays Flow Cytometry Services Clinical Trial Services Phase I Clinical Trials Phase II Clinical Trials Phase III Clinical Trials Phase IV / Post-Marketing Data Management & eClinical Biostatistics & Statistical Programming Medical Writing Pharmacovigilance & Drug Safety Regulatory Affairs US FDA Regulatory Strategy EU EMA Regulatory Strategy Japan PMDA Regulatory Strategy China NMPA Regulatory Strategy Analytical Method Development & Validation ICH Stability Studies Translational Research
Modalities	Small Molecule Biologics (Other) Cell Therapy Gene Therapy	Small Molecule Peptide Oligonucleotide Biologics (Monoclonal Antibodies) Biologics (Other) Antibody-Drug Conjugate (ADC) mRNA Cell Therapy Gene Therapy Vaccine
Indications	Cardiovascular Dermatology Gastroenterology Immunology Infectious Disease Metabolic Neurology Oncology Ophthalmology Psychiatry Respiratory Women's Health	Oncology Immunology Neurology Psychiatry Metabolic Cardiovascular Infectious Disease Rare Disease Respiratory Dermatology Ophthalmology Gastroenterology Nephrology Women's Health
Locations	Headquarters, Montreal, Quebec, Canada Bioanalytical Laboratory, Laval, Quebec, Canada Clinical Site, Montreal, Quebec, Canada Clinical and Research Campus, Overland Park, Kansas, United States Preclinical Testing, Everett, Washington, United States Manufacturing and Analytical Services, Harleysville, Pennsylvania, United States Preclinical Testing, Scranton, Pennsylvania, United States Preclinical Testing, Columbia, Missouri, United States Clinical Pharmacology, Cypress, California, United States Preclinical Testing, Sacramento, California, United States Laval, Laval, Quebec, Canada Overland Park, Overland Park, Kansas, United States Everett, Everett, Washington, United States Harleysville, Harleysville, Pennsylvania, United States Cypress, Cypress, California, United States Scott Township, Scott Township, Pennsylvania, United States Auxvasse, Auxvasse, Missouri, United States Sacramento, Sacramento, California, United States Canada, Canada, Canada United States, United States, United States Canada and U.S. operations	Headquarters, Shanghai, Pudong, China Global Operations, Asia, Europe, North America
Certifications	FDA · Identifier: FDA inspection passed 2001 GLP · Identifier: GLP Compliant GMP · Identifier: GMP Manufacturing	Data not yet provided.
Reviews	Review summary appears after site-level review signal gate opens.	Review summary appears after site-level review signal gate opens.